Literature DB >> 11790265

Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise.

Pitt O Lim1, Jayne A Morris-Thurgood, Michael P Frenneaux.   

Abstract

Approximately a third of patients with hypertrophic cardiomyopathy fail to increase blood pressure appropriately during exercise, a consequence of an inappropriate vasodilator response in nonexercising beds, leading to an exaggerated fall in systemic vascular resistance. The precise mechanism responsible for this abnormal vascular control in hypertrophic cardiomyopathy is still unclear, but is thought to be secondary to enhanced cardiac baroreceptor activity. However, alternate or synergistic mechanisms, including enhanced release of brain natriuretic peptide, may be involved. Normal exercise blood pressure responses have been shown to have a high (97%) negative predictive accuracy for sudden death during an average follow-up of approximately 3 years, providing considerable reassurance. Patients with abnormal blood pressure responses on exercise were at markedly increased risk of sudden cardiac death, although the positive predictive accuracy during this brief follow-up period was low (15%). It is likely that vascular instability may act as a trigger for sudden cardiac death in patients with an underlying electrophysiologic substrate. Recent evidence suggests that this vascular instability may also result in hypotension during ordinary daily activity, or even at rest, and may be an important cause of syncope in hypertrophic cardiomyopathy. Further studies are required to identify mechanisms of attenuating or reversing this vascular instability. Such measures might have the potential to improve symptoms of recurrent syncope and perhaps reduce the risk of sudden cardiac death.

Entities:  

Mesh:

Year:  2002        PMID: 11790265     DOI: 10.1097/00045415-200201000-00005

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  6 in total

1.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

2.  Hypotension in hereditary cardiomyopathy.

Authors:  Johny Al-Khoury; Danielle Jacques; Ghassan Bkaily
Journal:  Pflugers Arch       Date:  2022-02-09       Impact factor: 3.657

Review 3.  Sudden Cardiac Death in the Young.

Authors:  Michael Ackerman; Dianne L Atkins; John K Triedman
Journal:  Circulation       Date:  2016-03-08       Impact factor: 29.690

4.  Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.

Authors:  Marshall Heradien; Miriam Revera; Lize van der Merwe; Althea Goosen; Valerie A Corfield; Paul A Brink; Bongani M Mayosi; Johanna C Moolman-Smook
Journal:  Heart Rhythm       Date:  2009-09-01       Impact factor: 6.343

Review 5.  Hypertrophic cardiomyopathy as a cause of sudden death.

Authors:  Hubert Seggewiss; Christoph Blank; Barbara Pfeiffer; Angelos Rigopoulos
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

6.  Orthostatic blood pressure test for risk stratification in patients with hypertrophic cardiomyopathy.

Authors:  Julia Münch; Ali Aydin; Anna Suling; Christian Voigt; Stefan Blankenberg; Monica Patten
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.